CP
LLY icon

Clarendon Private’s Eli Lilly LLY Stock Holding History

Clarendon Private’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16M Buy
1,260
+190
+18% +$193K 0.89% 25
2025
Q4 		$1.15M Buy
1,070
+58
+6% +$55.5K 0.97% 26
2025
Q3 		$772K Sell
1,012
-100
-9% -$74.4K 0.7% 41
2025
Q2 		$867K Sell
1,112
-118
-10% -$91.7K 0.83% 31
2025
Q1 		$1.02M Sell
1,230
-251
-17% -$209K 1.07% 23
2024
Q4 		$1.14M Buy
+1,481
New +$1.23M 1.2% 20

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Clarendon Private's LLY Position: Q1 2026 in Review

Clarendon Private increased its Eli Lilly (LLY) stake by 18% in Q1 2026, buying an estimated $193K and bringing the position to 1,260 shares worth $1.16M. The position accounts for 0.89% of the portfolio, ranked #25.

Clarendon Private first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Clarendon Private held 1,260 shares of Eli Lilly worth $1.16M as of Q1 2026.
  • Clarendon Private bought 190 Eli Lilly shares in Q1 2026, an estimated $193K.
  • Eli Lilly made up 0.89% of Clarendon Private's portfolio in Q1 2026, its #25 holding.
  • Clarendon Private first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Clarendon Private's 13F filing for Q1 2026, filed 11 May 2026.